0
Skip to Content
Gyrus Capital
Home
Team
Purpose
Investment Approach
Portfolio
News
Investor Portal
Contact
Gyrus Capital
Home
Team
Purpose
Investment Approach
Portfolio
News
Investor Portal
Contact
Home
Team
Purpose
Investment Approach
Portfolio
News
Investor Portal
Contact

 Gyrus in the news

Essential Pharma announces the acquisition of Haldol®
Paul Tidy 07/12/2022 Paul Tidy 07/12/2022

Essential Pharma announces the acquisition of Haldol®

Read More

Gyrus Capital S.A.
1 Quai du Mont-Blanc,
1201 Geneva
Switzerland

info@gyruscapital.com

©2025 Gyrus Capital